Product Information

BRIMONIDINE 0.2% EYE DROP is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $0.5857 per ML under NDC 71921018510. Its NADAC has been published 220 times since Jun 8, 2022.

FDA first approved this application on Nov 18, 2014. Its Orange Book therapeutic-equivalence code is AT.

BRIMONIDINE 0.2% EYE DROP

Brimonidine Tartrate
$0.5857per ML

Strength

2 mg/mg

NDC

71921018510

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BRIMONIDINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091691

FDA Approved

11/18/2014

TE Code

AT

On Market Since

1/15/2022

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BRIMONIDINE 0.2% EYE DROP has been published 220 times since Jun 8, 2022, and over the history we have for it it has declined 10.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5857 per ML
All-time high$0.7361 (Sep 14, 2022)
All-time low$0.4128 (Nov 20, 2024)
52-week high$0.5910
52-week low$0.5553
Median price$0.5750
Average price$0.5775
Largest weekly change-26.2% (Nov 20, 2024)
Weeks tracked220
Tracking sinceJun 8, 2022

Price History

1W

+1.9%

1M

+1.9%

3M

+5.1%

6M

+1.3%

1Y

+4.2%

3Y

-1.7%

5Y

N/A

All

-10.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BRIMONIDINE 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE 0.2% EYE DROP, manufactured by Florida Pharmaceutical Products, LLC, is $0.5857 per ML (NDC 71921018510), effective Aug 19, 2026.

How has the price of BRIMONIDINE 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE 0.2% EYE DROP has declined 10.4%. It has been tracked across 220 weekly CMS publications since Jun 8, 2022.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE 0.2% EYE DROP?

Since Jun 8, 2022, the NADAC for BRIMONIDINE 0.2% EYE DROP has ranged from a low of $0.4128 (Nov 20, 2024) to a high of $0.7361 (Sep 14, 2022), with a median of $0.5750 per ML.

Are there cheaper alternatives to BRIMONIDINE 0.2% EYE DROP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE 0.2% EYE DROP, is $0.5086 per ML — about 13% below BRIMONIDINE 0.2% EYE DROP.

Who manufactures BRIMONIDINE 0.2% EYE DROP?

BRIMONIDINE 0.2% EYE DROP (NDC 71921018510) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.